Ciphergen Biosystems(CIPH): Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ciphergen Biosystems(CIPH):

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (41)	3/18/2002 4:52:27 PM
From: tuck	Read Replies (2) of 510

Peter, You wrote: "To properly understand this agreement we would need also to see the agreement between MAS and CTI." You asked for it -- you got it: sec.gov About the only difference is that this covers . . . >>1.18 "OTHER MARKETS" shall mean all Laboratories doing bioanalytical or biological measurements or assays which are not part of the Life Sciences Market or the Drug Discovery Market.<< >>1.6 "CTI FIELD OF USE" shall mean the scope of the grant to CTI set forth in Sections 2.1(a), 2.1(b) and 2.1(c) herein.<< In section 2, the language is exactly the same if one substitutes "Other Markets" for "Life Science Markets." Edit: Of course, one has to swap "CTI" and "Illumesys" in the parts concerning the Drug Discovery Market, too, but that makes no difference. So what do you mean by "I'm guessing Lumicyte has the CTI rights?" I don't know if you searched the AACR program use "SELDI" in the field. Much more than ovarian cancer is being done with multiple biomarkers, it would appear. I don't think the public at large has done the search, either. Watching CIPH closely for weakness, because I'm thinking that AACR will be big for it (in contrast to a statement I made before doing that search myself, in which I said I liked CIPH in the $4 range; I no longer see that kind of weakness, I'm talking nibbling in the low $6s and below now). Only problem is can't figure out whose customers are presenting papers. CIPH has a list of both academic and commercial customers in its S-1. I think I will try to match them with presenters tonight. I will post my findings. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next